Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection26

Select a period of time:

Views

Views
October 20240
November 20240
December 20241
January 20250
February 20252
March 20254
April 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore4
United States3
Germany1
Spain1
 

Top cities views

Views
Council Bluffs1